1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Foundation Medicine Acquires Lexent Bio

M&A Deal Summary

Foundation Medicine Acquires Lexent Bio

On June 12, 2020, Foundation Medicine acquired life science company Lexent Bio

Acquisition Highlights
  • This is Foundation Medicine’s 1st transaction in the Life Science sector.
  • This is Foundation Medicine’s 1st transaction in the United States.
  • This is Foundation Medicine’s 1st transaction in California.

M&A Deal Summary
Date 2020-06-12
Target Lexent Bio
Sector Life Science
Buyer(s) Foundation Medicine
Deal Type Add-on Acquisition

Target

Lexent Bio

San Francisco, California, United States
Lexent Bio, Inc. is an oncology company that develops novel multi-omics liquid biopsy platforms to advance cancer care. Lexent Bio is based in San Francisco, California.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Foundation Medicine

Cambridge, Massachusetts, United States
Category Company
Founded 2009
Sector Life Science
Employees417
Revenue 93M USD (2015)
DESCRIPTION

Foundation Medicine, Inc. is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal